Aug 2026· Pakistan journal of health sciences· 0 citations· 16 references
TL;DR
Blood eosinophilia was frequently observed among patients admitted with COPD exacerbation and showed a significant association with smoking status and exacerbation severity, as increasing severity was significantly associated with eosinophilia.
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide. Objectives: To determine the prevalence of eosinophilia in COPD exacerbation, and to evaluate its association with exacerbation severity. Methods: This cross-sectional study was conducted at the Department of Pulmonology, Indus Hospital and Health Network, Karachi, Pakistan, during April 2024 to September 2024. A total of 141 diagnosed cases of COPD patients were analyzed. Eosinophilia was labeled as a blood eosinophil count ≥ 2%. Stratification analysis was performed to observe the effects of effect modifiers on the prevalence of eosinophilia, applying Chi-square or Fisher's exact test, taking p<0.05 as statistically significant. Results: In a total of 141 patients, 101 (71.6%) were males, and the median age was 62.0 (52.0-71.0) years. Monthly family income was classified as low in 80 (56.7%) patients. Smoking status was ‘never smoked’ in 65 (46.1%), ‘ex-smoker’ in 61 (43.3%), and ‘current smoker’ in 15 (10.6%) patients. Hypertension and diabetes mellitus were reported in 92 (65.2%) and 73 (51.8%) patients. Eosinophilia was identified in 58 (41.1%) patients. Smoking status differed significantly with respect to the prevalence of eosinophilia (p=0.024). Severity of COPD exacerbation differed by eosinophilia status, as increasing severity was significantly associated with eosinophilia (p<0.001). Conclusions: Blood eosinophilia was frequently observed among patients admitted with COPD exacerbation and showed a significant association with smoking status and exacerbation severity.
Introduction: Chronic pulmonary diseases (CPD), such as COPD, bronchiectasis, and idiopathic pulmonary fibrosis (IPF), affect the airways and present with exacerbation episodes that compromise patients' quality of life. Objectives: To analyze the main causes of exacerbations in patients with CPD treated at the Medical...
Layla Emily Antunes Torres, Carolina Almeida Kapassi Jamielniaski, Estherfanny da Nóbrega Pinheiro et al.· Brazilian Journal of Implant...· 0 citations
Background: Acute exacerbation of COPD is one of the important problems during management of COPD & has considerable impact on morbidity, mortality and quality of life. Acute exacerbation can occur due to bacterial or viral infection & non-infectious causes. Sputum culture & real-time PCR can identify the pattern of ba...
M. Arif, Abdullah al Masud, A. H. Dip et al.· Chest & Heart Journal· 0 citations
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death and disability worldwide, with suboptimal treatment adherence. This study aimed to analyze factors associated with treatment adherence among COPD patients at the Lung Polyclinic of Prof. Dr. Chairudin P. Lubis Universitas Sumatera Utara Hospital....
Fajar Wira Perdana Kesuma Kesuma, A. Pradana, P. Pandia· Jurnal Kedokteran dan Keseha...· 0 citations
Chronic obstructive pulmonary disease (COPD) is a significant public health issue and ranks among the leading causes of morbidity and mortality globally.
This work aimed to examine the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the clinical and functional outcomes of COPD, as well as t...
Tasneem M. M. Abdelfatah, H. Salem, A. S. Elbendary et al.· Egyptian Journal of Chest Di...· 0 citations
BACKGROUND AND AIM: The prognosis of chronic obstructive pulmonary disease (COPD) depends on the frequency and severity of exacerbations. The DECAF score (dyspnea, eosinopenia, consolidation, acidemia, and atrial fibrillation) is a cost-effective tool used to predict exacerbation outcomes. This study examines its relat...
Ayşe Çifci, S. Duyar, D. Kaymaz et al.· Eurasian Journal of Pulmonol...· 0 citations
The global prevalence of chronic bronchitis (CB) ranges from 3.4% to 22%, while it ranges from 10% to 20% in the Russian Federation. These variations reflect differences in definitions and the association with the chronic obstructive pulmonary disease (COPD) phenotype. Among patients with COPD, the frequency of CB reac...
I. Leshchenko, А. N. (Mikheev)· PULMONOLOGIYA· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.